| Mon, Feb 8, 2010 |
| • |
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics
Business Wire (Mon, Feb 8)
|
| • |
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics
Business Wire (Mon, Feb 8)
|
| Mon, Feb 1, 2010 |
| • |
Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conference
Business Wire (Mon, Feb 1)
|
| Mon, Jan 25, 2010 |
| • |
Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21
Business Wire (Mon, Jan 25)
|
| Thu, Jan 21, 2010 |
| • |
The Noble Gesture That Wasn't
at Motley Fool (Thu, Jan 21)
|
| Wed, Jan 20, 2010 |
| • |
BIO Ventures for Global Health Chosen as Administrator of Intellectual Property Pool Involving GSK and Alnylam as Participants
Business Wire (Wed, Jan 20)
|
| Tue, Jan 19, 2010 |
| • |
Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium
Business Wire (Tue, Jan 19)
|
| • |
Alnylam and Collaborators Discover Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Vivo Potency for RNAi Therapeutics
Business Wire (Tue, Jan 19)
|
| Fri, Jan 15, 2010 |
| • |
Alnylams Kreutzer-Limmer I Patent Upheld in German Opposition Proceedings
Business Wire (Fri, Jan 15)
|
| • |
Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium
Business Wire (Fri, Jan 15)
|
| Thu, Jan 14, 2010 |
| • |
Alnylam Pharma Guides
Zacks.com (Thu, Jan 14)
|
| Mon, Jan 11, 2010 |
| • |
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
Business Wire (Mon, Jan 11)
|
| • |
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Business Wire (Mon, Jan 11)
|
| Fri, Jan 8, 2010 |
| • |
Alnylam and Collaborators Discover Key Mechanism for Delivery of RNAi Therapeutics
Business Wire (Fri, Jan 8)
|
| Wed, Jan 6, 2010 |
| • |
Alnylam to Webcast Presentation at the 28th Annual J.P. Morgan Healthcare Conference
Business Wire (Wed, Jan 6)
|
| • |
Alnylam Pharma gets milestone payment from Roche
AP (Wed, Jan 6)
|
| • |
Alnylam Receives Milestone Payment from Roche Related to Advancement of RNAi Therapeutics
Business Wire (Wed, Jan 6)
|
| Tue, Dec 29, 2009 |
| • |
Alnylam and Collaborators at MIT Report New Pre-clinical Research on Systemic Delivery of RNAi Therapeutics
Business Wire (Tue, Dec 29)
|
| Thu, Dec 17, 2009 |
| • |
Regulus Therapeutics Receives Exclusive License for Intellectual Property on Immuno-inflammatory microRNAs from the California Institute of Technology
Business Wire (Thu, Dec 17)
|
| Tue, Dec 15, 2009 |
| • |
Isis and Alnylam Announce Notice of Allowance for New U.S. Patent Application Broadly Covering RNAi Therapeutics
Business Wire (Tue, Dec 15)
|
| Wed, Dec 9, 2009 |
| • |
Regulus Therapeutics Inc. presents: MicroRNA: The Year in Review and a Look Ahead
Business Wire (Wed, Dec 9)
|
| Older Headlines |
|
|
|
|
Help
Headlines
